高级检索
当前位置: 首页 > 详情页

Predicting NSCLC surgical outcomes using deep learning on histopathological images: development and multi-omics validation of Sr-PPS model

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Radiology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, Sichuan Province, China. [2]Department of Thoracic Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, Sichuan Province, China. [3]Hyperbaric Oxygen Therapy Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 611731, China. [4]Department of Oncology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 611731, China. [5]Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China. [6]Institute of Thoracic Oncology and Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
出处:
ISSN:

关键词: Deep learning Non-small cell lung cancer Surgery Prognosis Biomarker

摘要:
Currently, there remains a critical need for reliable tools to accurately predict post-surgical outcomes in non-small cell lung cancer (NSCLC) patients in clinical practice. We aimed to develop and validate a deep learning-based model utilizing histopathological slides to accurately predict post-surgical outcomes in NSCLC patients.In this study, we analyzed histopathological slides and comprehensive clinical data from 337 Local-NSCLC patients for model development, and further validated the model using an independent cohort of 554 NSCLC patients from The Cancer Genome Atlas (TCGA) database. Utilizing the advanced Res2Net deep learning architecture, we developed and optimized a novel Surgical Prognosis Prediction Score (Sr-PPS) system.The Sr-PPS model demonstrated significantly enhanced predictive accuracy for both disease-free survival (DFS) and overall survival (OS) in NSCLC patients. Multivariate Cox regression analysis validated Sr-PPS as a robust independent predictor of post-surgical outcomes in NSCLC patients. Patients with low Sr-PPS scores exhibited enhanced anti-tumor immune microenvironment characteristics, characterized by significant upregulation of immune activation pathways (particularly T-cell migration and B-cell receptor signaling), coupled with marked downregulation of oncogenic pathways, including insulin-like growth factor receptor signaling and STAT protein phosphorylation. Further genomic analyses revealed significant associations between Sr-PPS scores and mutations in key oncogenic driver genes, including CTNND2, PRRX1, and ALK.Our deep learning-based Sr-PPS model not only demonstrates robust predictive capability for post-surgical outcomes in NSCLC patients but also elucidates underlying molecular mechanisms, thereby providing a valuable framework for personalized treatment stratification.Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 2 区 医学
小类 | 2 区 外科
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 外科
JCR分区:
出版当年[2024]版:
Q1 SURGERY
最新[2024]版:
Q1 SURGERY

影响因子: 最新[2024版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Department of Radiology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, Sichuan Province, China.
共同第一作者:
通讯作者:
通讯机构: [2]Department of Thoracic Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, Sichuan Province, China. [6]Institute of Thoracic Oncology and Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65780 今日访问量:0 总访问量:5151 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号